# tgfbr1-biomarker-analysis
Computational pipeline for identifying FDA-approved drugs for repurposing against TGF-βR1 in Triple-Negative Breast Cancer (TNBC). Includes survival analysis validating TGF-βR1 as a prognostic biomarker and molecular docking results.
